SEC Form D · filed November 30, 2020
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
James K. Anderson · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorJack W. Reich · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecJames W. Newman, Jr · Charlottesville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorBankole A. Johnson · Charlottesville, VAExecTony W. Goodman · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorPeter Feld · New York, NYDirectorSever Totia · New York, NYDirectorNaman Shah · San Francisco, CADirectorJesse S. Jacobs · Playa Vista, CADirectorMike Kerns · Playa Vista, CADirectorKweli Washington · New York, NYDirectorGina Mondo · Norwich, CTExec · DirectorW. C. Mccollum · Los Angeles, CAExecJason Bergsman · Playa Vista, CAExecUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorJamie Bateman · Cockeysville, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗